Pazopanib Hydrochloride
Records for this ingredient, by country (identity only).
ATC L01XE11 · 4 markets · 27 records
FR 14 records · 4 shown of 4
- 200 mgtabletPAZOPANIB ACCORD 200 mg, comprimé pelliculéPAZOPANIB BIOGARAN 200 mg, comprimé pelliculé、PAZOPANIB EG 200 mg, comprimé pelliculé、PAZOPANIB TEVA 200 mg, comprimé pelliculé、PAZOPANIB VIATRIS 200 mg, comprimé pelliculé、PAZOPANIB ZENTIVA 200 mg, comprimé pelliculé
- 400 mgtabletPAZOPANIB ACCORD 200 mg, comprimé pelliculéPAZOPANIB BIOGARAN 200 mg, comprimé pelliculé、PAZOPANIB EG 200 mg, comprimé pelliculé、PAZOPANIB TEVA 200 mg, comprimé pelliculé、PAZOPANIB VIATRIS 200 mg, comprimé pelliculé、PAZOPANIB ZENTIVA 200 mg, comprimé pelliculé
- 433.4 mgtabletVOTRIENT 200 mg, comprimé pelliculé
- 216.7 mgtabletVOTRIENT 200 mg, comprimé pelliculé
AU 8 records · 4 shown of 4
- 433.4 mgtabletPAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottlePAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle、VOTRIENT pazopanib 400 mg tablet bottle
- 216.7 mgtabletPAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottlePAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle、VOTRIENT pazopanib 400 mg tablet bottle
- 433 mgtabletPAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle
- 216.5 mgtabletPAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle
SG 4 records · 2 shown of 2
- 200 mgtabletPAZOPANIB-TEVA FC TABLETS 200 MGTYROKA FILM-COATED TABLETS 200 MG、VOTRIENT
- 400 mgtabletVOTRIENT
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | AU | SG | EU | FR |
|---|---|---|---|---|
| 200 mg tablet | PAZOPANIB-TEVA FC TABLETS 200 MG TYROKA FILM-COATED TABLETS 200 MG VOTRIENT | PAZOPANIB ACCORD 200 mg, comprimé pelliculé PAZOPANIB BIOGARAN 200 mg, comprimé pelliculé PAZOPANIB EG 200 mg, comprimé pelliculé | ||
| 400 mg tablet | VOTRIENT | PAZOPANIB ACCORD 200 mg, comprimé pelliculé PAZOPANIB BIOGARAN 200 mg, comprimé pelliculé PAZOPANIB EG 200 mg, comprimé pelliculé | ||
| 433.4 mg tablet | PAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottle PAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle VOTRIENT pazopanib 400 mg tablet bottle | VOTRIENT 200 mg, comprimé pelliculé | ||
| 216.7 mg tablet | PAZOPANIB DR. REDDY'S pazopanib (as hydrochloride) 200 mg film coated tablet bottle PAZOPANIB-RZ pazopanib (as hydrochloride) 200 mg film coated tablet bottle VOTRIENT pazopanib 400 mg tablet bottle | VOTRIENT 200 mg, comprimé pelliculé | ||
| 433 mg tablet | PAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle | |||
| 216.5 mg tablet | PAZOPANIB ADVZ pazopanib (as hydrochloride) 200 mg tablet bottle | |||
unknown | VOTRIENT |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 EU 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.